Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| GENOCEA BIOSCIENCES, INC. | 2 064 888 | déclaré | 12 août 2014 | tx 3−63 794 |
| T2 Biosystems, Inc. | 58 072 | déclaré | 24 juil. 2015 | tx 28−90 394 |
| Ruthigen, Inc. | 18 600 | déclaré | 15 juin 2015 | tx 10+1 243 662 |
| Cardlytics, Inc. | 16 885 | déclaré | 13 sept. 2018 | tx 16−150 000 |
| X4 Pharmaceuticals, Inc | 5 110 | déclaré | 20 nov. 2017 | tx 44+1 868 957−3 969 854 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 1 477 | 24.67 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 75 805 | 24.67 USD | anomalie |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 26 | 26.41 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 456 | 25.52 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 205 | 25.19 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 760 | 24.67 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 17 | 26.42 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 314 | 25.52 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 143 | 25.19 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 518 | 24.67 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 49 | 26.41 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 45 743 | 25.52 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 2 504 | 26.41 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 20 688 | 25.19 USD | |
| 12 sept. 2018 | SALE | Cardlytics, Inc. | 404 | 25.19 USD | |
| 13 sept. 2018 | SALE | Cardlytics, Inc. | 891 | 25.52 USD | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 12 298 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 4 322 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 631 041 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 1 102 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 755 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 2 150 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 110 312 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 3 173 | — | |
| 20 nov. 2017 | CONVERSION | X4 Pharmaceuticals, Inc | 6 310 | — |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 20 nov. 2017.